Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies

被引:132
作者
Arora, D [1 ]
Khanna, N [1 ]
机构
[1] INT CTR GENET ENGN & BIOTECHNOL,RECOMBINANT GENE PROD GRP,NEW DELHI 110067,INDIA
关键词
gamma-interferon; purification; refolding; downstream processing;
D O I
10.1016/S0168-1656(96)01636-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A strategy is described for improved refolding and purification of recombinant human gamma interferon (rh-IFN gamma), which could warrant a higher yield and specific activity than reported previously. The optimal conditions of refolding are obtained by addition of a labilizing agent, L-arginine, in the refolding buffer. A 10-fold increase in the yield was observed with 0.5 M L-arginine, compared with renaturation in its absence. By varying renaturation parameters, the conditions that allow functional refolding of similar to 25-30% of the recombinant protein have been standardized. A simple process is also described for the purification of rh-IFN gamma. The purification involves a single-column chromatography on S-Sepharose, after refolding of rh-IFN gamma in arginine containing buffer. This procedure has consistently produced rh-IFN gamma having a purity of at least 97%, the rest being the aggregated form of gamma interferon. The purified protein is a dimer under non-denaturing conditions and has a specific activity of 2 x 10(8) IU mg(-1) protein, as measured by viral cytopathic assay. (C) 1996 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 14 条
[1]  
ARAKAWA T, 1985, J BIOL CHEM, V260, P4435
[2]   A METHOD FOR INCREASING THE YIELD OF PROPERLY FOLDED RECOMBINANT FUSION PROTEINS - SINGLE-CHAIN IMMUNOTOXINS FROM RENATURATION OF BACTERIAL INCLUSION-BODIES [J].
BUCHNER, J ;
PASTAN, I ;
BRINKMANN, U .
ANALYTICAL BIOCHEMISTRY, 1992, 205 (02) :263-270
[3]   RENATURATION, PURIFICATION AND CHARACTERIZATION OF RECOMBINANT FAB-FRAGMENTS PRODUCED IN ESCHERICHIA-COLI [J].
BUCHNER, J ;
RUDOLPH, R .
BIO-TECHNOLOGY, 1991, 9 (02) :157-162
[4]  
KUNG H, 1994, Patent No. 5278286
[5]   STRUCTURE OF INTERFERONS [J].
LANGER, JA ;
PESTKA, S .
PHARMACOLOGY & THERAPEUTICS, 1985, 27 (03) :371-401
[6]  
LEWIS JA, 1988, CYTOKINES, P108
[7]  
MAREKOV LN, Patent No. 0446582
[8]  
NAGABHUSAN TL, 1989, Patent No. 4751078
[9]   OLIGOMERIC STRUCTURE OF RECOMBINANT HUMAN AND MURINE IMMUNE INTERFERONS BY MEANS OF SEDIMENTATION EQUILIBRIUM [J].
NAGATA, K ;
IZUMI, T ;
KITAGAWA, T ;
YOSHIDA, N .
JOURNAL OF INTERFERON RESEARCH, 1987, 7 (03) :313-320
[10]   INTERFERONS AND THEIR ACTIONS [J].
PESTKA, S ;
LANGER, JA ;
ZOON, KC ;
SAMUEL, CE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :727-777